$MCOM
micromobility.com Inc. Stock $mcom

$mcom Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000107997324000555 Filed on April 16, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$787.0K	$876.0K	$9.844M
YoY Change	-77.48%	-79.09%	-36.65%
Cost Of Revenue	$977.0K	$1.753M	$28.98M
YoY Change	-92.2%	-84.98%	-30.39%
Gross Profit	-$190.0K	-$877.0K	-$19.13M
YoY Change	-97.9%	-88.28%	-26.66%
Gross Profit Margin	-24.14%	-100.11%	-194.34%
Selling, General & Admin	$1.488M	$6.936M	$26.45M
YoY Change	-75.86%	-16.63%	-24.96%
% of Gross Profit
Research & Development		$335.0K	$2.439M
YoY Change		-52.82%	-11.02%
% of Gross Profit
Depreciation & Amortization	$327.0K	$819.0K	$5.529M
YoY Change	-81.63%	-53.73%	12.1%
% of Gross Profit
Operating Expenses	$2.498M	$7.378M	$73.85M
YoY Change	-93.04%	-18.29%	-17.06%
Operating Profit	-$1.711M	-$8.255M	-$64.01M
YoY Change	-94.72%	-50.0%	-12.91%
Interest Expense	$840.0K	-$1.752M	-$6.010M
YoY Change	-145.04%	-19.26%	-184.16%
% of Operating Profit
Other Income/Expense, Net	$161.0K	-$21.00K	$2.010M
YoY Change	-109.03%	-106.77%	-123.51%
Pretax Income	-$1.550M	$1.205M	-$62.00M
YoY Change	-95.47%	-106.56%	-24.44%
Income Tax		$10.00K	$58.00K
% Of Pretax Income		0.83%
Net Earnings	-$1.550M	$1.194M	-$62.06M
YoY Change	-95.47%	-106.5%	-24.39%
Net Earnings / Revenue	-196.95%	136.3%	-630.38%
Basic Earnings Per Share	-$0.03		-$42.90
Diluted Earnings Per Share	-$0.03	$0.26	-$42.90
COMMON SHARES
Basic Shares Outstanding	45.19M shares	285.5M shares	1.446M shares
Diluted Shares Outstanding	60.86M shares		1.446M shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$162.0K	$128.0K	$128.0K
YoY Change	-68.24%	-70.23%	-70.23%
Cash & Equivalents	$162.0K	$128.0K	$128.0K
Short-Term Investments
Other Short-Term Assets	$1.003M	$1.219M	$1.219M
YoY Change	-58.55%	-69.9%	-69.9%
Inventory
Prepaid Expenses		$49.00K
Receivables	$515.0K	$704.0K	$753.0K
Other Receivables	$129.0K	$928.0K	$928.0K
Total Short-Term Assets	$1.938M	$3.028M	$3.028M
YoY Change	-63.52%	-73.07%	-73.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.680M	$2.435M	$3.615M
YoY Change	-52.74%	-73.64%	-70.15%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$392.0K	$389.0K	$389.0K
YoY Change	-38.07%	-44.98%	-45.21%
Total Long-Term Assets	$2.784M	$4.004M	$4.004M
YoY Change	-58.1%	-86.61%	-86.61%
TOTAL ASSETS
Total Short-Term Assets	$1.938M	$3.028M	$3.028M
Total Long-Term Assets	$2.784M	$4.004M	$4.004M
Total Assets	$4.722M	$7.032M	$7.032M
YoY Change	-60.51%	-82.91%	-82.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$18.40M	$22.99M	$22.99M
YoY Change	-25.0%	4.08%	4.08%
Accrued Expenses	$2.471M	$1.920M	$9.944M
YoY Change	16.83%	-18.95%	-3.92%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$15.56M	$13.60M	$13.60M
YoY Change	-39.21%	-61.43%	-61.43%
Total Short-Term Liabilities	$50.75M	$48.09M	$48.09M
YoY Change	-17.11%	-32.01%	-32.01%
LONG-TERM LIABILITIES
Long-Term Debt	$1.357M	$1.842M	$1.842M
YoY Change	-79.96%	-74.59%	-74.59%
Other Long-Term Liabilities	$14.00K	$42.00K	$903.0K
YoY Change	-96.09%	-88.4%	-56.59%
Total Long-Term Liabilities	$14.00K	$42.00K	$2.745M
YoY Change	-96.09%	-88.4%	-70.58%
TOTAL LIABILITIES
Total Short-Term Liabilities	$50.75M	$48.09M	$48.09M
Total Long-Term Liabilities	$14.00K	$42.00K	$2.745M
Total Liabilities	$52.71M	$50.83M	$50.83M
YoY Change	-24.47%	-36.5%	-36.51%
SHAREHOLDERS EQUITY
Retained Earnings	-$258.1M	-$252.0M
YoY Change	5.89%	32.67%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$47.99M	-$43.80M	-$43.80M
YoY Change
Total Liabilities & Shareholders Equity	$4.722M	$7.032M	$7.032M
YoY Change	-60.51%	-82.91%	-82.91%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$1.550M	$1.194M	-$62.06M
YoY Change	-95.47%	-106.5%	-24.39%
Depreciation, Depletion And Amortization	$327.0K	$819.0K	$5.529M
YoY Change	-81.63%	-53.73%	12.1%
Cash From Operating Activities	-$518.0K	-$6.281M	-$37.47M
YoY Change	-94.21%	-13.01%	-13.05%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$493.0K	$1.493M
YoY Change	-100.0%	-305.42%	-55.7%
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	$0.00	-$493.0K	-$1.493M
YoY Change	-100.0%	49.39%	-77.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	537.0K	6.511M	$37.63M
YoY Change	-93.61%	24.49%	27.15%
NET CHANGE
Cash From Operating Activities	-518.0K	-6.281M	-$37.47M
Cash From Investing Activities	0.000	-493.0K	-$1.493M
Cash From Financing Activities	537.0K	6.511M	$37.63M
Net Change In Cash	19.00K	-263.0K	-$593.0K
YoY Change	-102.71%	-88.66%	-97.11%
FREE CASH FLOW
Cash From Operating Activities	-$518.0K	-$6.281M	-$37.47M
Capital Expenditures	$0.00	$493.0K	$1.493M
Free Cash Flow	-$518.0K	-$6.774M	-$38.96M
YoY Change	-94.31%	-2.95%	-16.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001788841
CY2023Q4	us-gaap	Goodwill Goodwill		usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022	mcom	Sepa Financial Expenses Net SepaFinancialExpensesNet		usd
CY2023	mcom	Deemed Dividends And Deemed Dividends Equivalents DeemedDividendsAndDeemedDividendsEquivalents		usd
CY2022	mcom	Deemed Dividends And Deemed Dividends Equivalents DeemedDividendsAndDeemedDividendsEquivalents		usd
CY2022	mcom	Issuance Of Series Preferred Stock For Wheels Business Combination IssuanceOfSeriesPreferredStockForWheelsBusinessCombination		usd
CY2023	mcom	Class B Shares Of Common Stock Conversion Into Class Shares Of Common Stock ClassBSharesOfCommonStockConversionIntoClassSharesOfCommonStock		usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2023	mcom	Proceeds From Issuance Of Financial Liabilities Due To Related Party Officer ProceedsFromIssuanceOfFinancialLiabilitiesDueToRelatedPartyOfficer		usd
CY2023	mcom	Repayment Of Financial Liabilities To Related Party Officer RepaymentOfFinancialLiabilitiesToRelatedPartyOfficer		usd
CY2023	mcom	Payments Of Offering Costs And Underwriting Discounts And Commissions PaymentsOfOfferingCostsAndUnderwritingDiscountsAndCommissions		usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent		usd
CY2023	mcom	Issuance Of Common Shares For Settlement Of Current Financial Liabilities IssuanceOfCommonSharesForSettlementOfCurrentFinancialLiabilities		usd
CY2022	mcom	Issuance Of Common Stock For Preferred Share Conversion IssuanceOfCommonStockForPreferredShareConversion		usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1		usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1		usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1		usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1		usd
CY2023	us-gaap	Stock Issued1 StockIssued1		usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1		usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Warrants Issued1 NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsIssued1		shares
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1		usd
CY2023	us-gaap	Notes Issued1 NotesIssued1		usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1		usd
CY2023	mcom	Goodwill Business Combination Value GoodwillBusinessCombinationValue		usd
CY2023	mcom	Goodwill Fx Rate Adjustment Value GoodwillFxRateAdjustmentValue		usd
CY2023Q4	us-gaap	Goodwill Goodwill		usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent		usd
CY2023Q4	us-gaap	Other Indefinite Lived Intangible Assets OtherIndefiniteLivedIntangibleAssets		usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross		usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization		usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet		usd
CY2022	mcom	Secured Convertible Loan SecuredConvertibleLoan		usd
CY2022	mcom	Sepas Transaction Costs SepasTransactionCosts		usd
CY2022	mcom	Other Sepa Financial Income Expenses Net OtherSepaFinancialIncomeExpensesNet		usd
CY2022	mcom	Total Sepa Financial Income Expenses Net TotalSepaFinancialIncomeExpensesNet		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment		usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets		usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets		usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment		usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-39136
CY2023	dei	Entity Registrant Name EntityRegistrantName	micromobility.com, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-3015108
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	500 Broome Street
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	5500000	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	45185172	shares
CY2023	dei	Auditor Firm AuditorFirmId	688
CY2023	dei	Auditor Name AuditorName	Marcum LLP
CY2023	dei	Auditor Location AuditorLocation	New York, NY
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	128000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	429000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	704000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1345000	usd
CY2023Q4	mcom	Prepaid Media Rights PrepaidMediaRights	49000	usd
CY2022Q4	mcom	Prepaid Media Rights PrepaidMediaRights	2366000	usd
CY2023Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	928000	usd
CY2022Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	3054000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1219000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4051000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	3028000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	11245000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2435000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9237000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1180000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2872000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	389000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	707000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	13826000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3267000	usd
CY2023Q4	us-gaap	Assets Assets	7032000	usd
CY2022Q4	us-gaap	Assets Assets	41154000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	11598000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	14359000	usd
CY2023Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	11394000	usd
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	7732000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	9482000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	8885000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1558000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3047000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	462000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1463000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	67000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2002000	usd
CY2023Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	13528000	usd
CY2022Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	33244000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	48089000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	70732000	usd
CY2023Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	1842000	usd
CY2022Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	7174000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	861000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1719000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	42000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	433000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	50834000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	80058000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2144000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2904000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-251997000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-189942000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-43802000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-39850000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7032000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	41154000	usd
CY2023	us-gaap	Revenues Revenues	9844000	usd
CY2022	us-gaap	Revenues Revenues	15538000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	28975000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	41625000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22917000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25569000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	16683000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	10390000	usd
CY2023	us-gaap	Business Development BusinessDevelopment	2837000	usd
CY2022	us-gaap	Business Development BusinessDevelopment	8712000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2439000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2741000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	73851000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	89037000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-64007000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-73499000	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-6010000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-7141000	usd
CY2023	mcom	Sepa Financial Expenses Net SepaFinancialExpensesNet	4215000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	12032000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2065000	usd
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	202000	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	655000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2010000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8551000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	58000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-62055000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-82074000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-62055000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-82074000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-42.90
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-42.90
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-9360.49
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1446391	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8768	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8768	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-62055000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-82074000	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	-760000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	2283000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-61295000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-84357000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-7849000	usd
CY2022	mcom	Issuance Of Common Shares For Conversion Of Convertible Notes IssuanceOfCommonSharesForConversionOfConvertibleNotes	43785000	usd
CY2022	mcom	Reclassification Of Bifurcated Embedded Conversion Option Pursuant To Adoption Of Accounting Pronouncement Asu202006 ReclassificationOfBifurcatedEmbeddedConversionOptionPursuantToAdoptionOfAccountingPronouncementAsu202006	-3371000	usd
CY2022	mcom	Issuance Of Warrants IssuanceOfWarrants	790000	usd
CY2022	mcom	Issuance Of Common Shares Commitment Shares For Convertible Notes Issuance IssuanceOfCommonSharesCommitmentSharesForConvertibleNotesIssuance	399000	usd
CY2022	mcom	Issuance Of Shares Of Common Stock For Legal Services Rendered In Connection With Issuance Of Convertible Notes IssuanceOfSharesOfCommonStockForLegalServicesRenderedInConnectionWithIssuanceOfConvertibleNotes	451000	usd
CY2022	mcom	Issuance Of Common Shares For Advance Notices Under Sepa IssuanceOfCommonSharesForAdvanceNoticesUnderSepa	3169000	usd
CY2022	mcom	Issuance Of Common Shares For Legal Services Rendered In Connection With Sepa IssuanceOfCommonSharesForLegalServicesRenderedInConnectionWithSepa	220000	usd
CY2022	mcom	Issuance Of Common Shares For Settlement Of Account Payables IssuanceOfCommonSharesForSettlementOfAccountPayables	770000	usd
CY2022	mcom	Issuance Of Common Shares For Settlement Of Financial Liabilities IssuanceOfCommonSharesForSettlementOfFinancialLiabilities	2443000	usd
CY2022	mcom	Issuance Of Common Shares For Settlement Of Payroll Liabilities IssuanceOfCommonSharesForSettlementOfPayrollLiabilities	335000	usd
CY2022	mcom	Reclassification Of Liability Warrants To Equity Warrants ReclassificationOfLiabilityWarrantsToEquityWarrants	56000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3310000	usd
CY2022	mcom	Changes In Currency Translation Adjustment ChangesInCurrencyTranslationAdjustment	-2283000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-82074000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-39850000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-39850000	usd
CY2023	mcom	Issuance Of Common Shares For Advance Notice Under Sepa IssuanceOfCommonSharesForAdvanceNoticeUnderSepa	54192000	usd
CY2023	mcom	Issuance Of Common Shares For Conversion Of Convertible Notes IssuanceOfCommonSharesForConversionOfConvertibleNotes	1296000	usd
CY2023	mcom	Issuance Of Common Stock For Conversion Of Series Convertible Preferred Stocks IssuanceOfCommonStockForConversionOfSeriesConvertiblePreferredStocks	945000	usd
CY2023	mcom	Issuance Of Shares Of Common Stock And Warrants For Various Operating And Investing Activities IssuanceOfSharesOfCommonStockAndWarrantsForVariousOperatingAndInvestingActivities	452000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	456000	usd
CY2023	mcom	Changes In Currency Translation Adjustment ChangesInCurrencyTranslationAdjustment	760000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-62055000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-43802000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-62055000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-82074000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5529000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6158000	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-3173000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-193000	usd
CY2023	us-gaap	Interest Expense Trust Preferred Securities InterestExpenseTrustPreferredSecurities	2267000	usd
CY2022	us-gaap	Interest Expense Trust Preferred Securities InterestExpenseTrustPreferredSecurities	5768000	usd
CY2023	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	12032000	usd
CY2022	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	-2065000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	456000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3310000	usd
CY2023	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	16683000	usd
CY2022	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	10390000	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1363000	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1706000	usd
CY2023	mcom	Other Noncash Items Related To Licensing OtherNoncashItemsRelatedToLicensing	-84000	usd
CY2022	mcom	Other Noncash Items Related To Licensing OtherNoncashItemsRelatedToLicensing	-1465000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-6072000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2890000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-292000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	348000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-641000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	894000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1268000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	7733000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-710000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1529000	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-333000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-57000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-37470000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-43095000	usd
CY2023	us-gaap	Payments To Acquire Oil And Gas Property And Equipment PaymentsToAcquireOilAndGasPropertyAndEquipment	1258000	usd
CY2022	us-gaap	Payments To Acquire Oil And Gas Property And Equipment PaymentsToAcquireOilAndGasPropertyAndEquipment	3151000	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	235000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	222000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	3167000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1493000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6540000	usd
CY2023	mcom	Proceeds From Issuance Of Financial Liabilities Net ProceedsFromIssuanceOfFinancialLiabilitiesNet	14548000	usd
CY2022	mcom	Proceeds From Issuance Of Financial Liabilities Net ProceedsFromIssuanceOfFinancialLiabilitiesNet	32265000	usd
CY2023	mcom	Repayment Of Financial Liabilities RepaymentOfFinancialLiabilities	31109000	usd
CY2022	mcom	Repayment Of Financial Liabilities RepaymentOfFinancialLiabilities	5489000	usd
CY2022	mcom	Proceeds From Issuance Of Financial Liabilities Due To Related Party Officer ProceedsFromIssuanceOfFinancialLiabilitiesDueToRelatedPartyOfficer	492000	usd
CY2022	mcom	Repayment Of Financial Liabilities To Related Party Officer RepaymentOfFinancialLiabilitiesToRelatedPartyOfficer	237000	usd
CY2023	mcom	Proceeds From Sale Of Class Common Shares Net ProceedsFromSaleOfClassCommonSharesNet	54192000	usd
CY2022	mcom	Proceeds From Sale Of Class Common Shares Net ProceedsFromSaleOfClassCommonSharesNet	3169000	usd
CY2022	mcom	Payments Of Offering Costs And Underwriting Discounts And Commissions PaymentsOfOfferingCostsAndUnderwritingDiscountsAndCommissions	605000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	37631000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	29595000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1332000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-20040000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	740000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-475000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-593000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-20515000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	737000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21252000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	143000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	737000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	128000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	429000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	15000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	276000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	32000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	143000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	737000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	3448000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	1375000	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	58000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	28000	usd
CY2023	mcom	Convertible Debts Converted Into Common Shares ConvertibleDebtsConvertedIntoCommonShares	1296000	usd
CY2022	mcom	Convertible Debts Converted Into Common Shares ConvertibleDebtsConvertedIntoCommonShares	43785000	usd
CY2022	mcom	Issuance Of Common Shares For Settlement Of Current Financial Liabilities IssuanceOfCommonSharesForSettlementOfCurrentFinancialLiabilities	2443000	usd
CY2023	mcom	Issuance Of Common Stock For Preferred Share Conversion IssuanceOfCommonStockForPreferredShareConversion	945000	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	182000	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	151000	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	50000	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	69000	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	399000	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	451000	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Warrants Issued1 NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsIssued1	790000	shares
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	4187000	usd
CY2022	us-gaap	Notes Issued1 NotesIssued1	945000	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	4273000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zQhweyiTH4Ab" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><b><span id="xdx_86F_zQtYeBvZk2Z7">Use of Estimates </span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 20pt">The preparation of financial statements in conformity with US GAAP generally requires management to make estimates and assumptions that affect the reported amount of certain assets, liabilities, revenues, and expenses, and the related disclosure of contingent assets and liabilities. Specific accounts that require management estimates include determination of fair values of warrant and financial instruments, purchase price allocation for business combinations, useful lives of intangible assets, property and equipment and valuation allowance for deferred income taxes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 20pt">Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</p>
CY2022Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2023Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2023Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zCOWFnvGeBuk" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b><span id="xdx_86F_zD00EwCUhtvh">Concentration of Credit Risk </span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 20pt">Cash and cash equivalents, restricted cash are potentially subject to credit risk concentration. Cash and cash equivalents and restricted cash consist of cash deposits which typically exceed insured limits and are placed with international financial institutions. The Company has not experienced any material losses related to these concentrations during the periods presented.</p>
CY2023	mcom	Revenue Recognition Customer Acquisition RevenueRecognitionCustomerAcquisition	<p id="xdx_844_ecustom--RevenueRecognitionCustomerAcquisition_z9uKxaem7oXb" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b><span id="xdx_86A_zEqz9bp3uze1">Acquisitions </span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 20pt">The Company accounts for acquisitions of entities or asset groups that qualify as businesses using the acquisition method of accounting. In detail, the acquisition method required that the purchase price of the acquisition is allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values at the acquisition date. The excess of the purchase price over those fair values is recorded as goodwill. During the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded in the consolidated statements of operations.</p>
CY2022	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	21196000	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-111484000	usd
CY2023	us-gaap	Revenues Revenues	9844000	usd
CY2022	us-gaap	Revenues Revenues	15538000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	3047000	usd
CY2023	mcom	Deferred Revenue Additions Value DeferredRevenueAdditionsValue	4916000	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6156000	usd
CY2023	mcom	Deferred Revenue Fx Rate Adjustment Value DeferredRevenueFxRateAdjustmentValue	-248000	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	1558000	usd
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	1585000	usd
CY2022	mcom	Deferred Revenue Additions Value DeferredRevenueAdditionsValue	10320000	usd
CY2022	mcom	Deferred Revenue Wheels Business Combination Value DeferredRevenueWheelsBusinessCombinationValue	322000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	8948000	usd
CY2022	mcom	Deferred Revenue Fx Rate Adjustment Value DeferredRevenueFxRateAdjustmentValue	-231000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	3047000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2758000	usd
CY2022	mcom	Prepaid Media Rights Additions PrepaidMediaRightsAdditions	13550000	usd
CY2022	mcom	Prepaid Media Rights Cogs PrepaidMediaRightsCogs	-13767000	usd
CY2022	mcom	Prepaid Media Rights Fx Rate Adjustment Value PrepaidMediaRightsFxRateAdjustmentValue	-175000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2366000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2366000	usd
CY2023	mcom	Prepaid Media Rights Additions PrepaidMediaRightsAdditions	5101000	usd
CY2023	mcom	Prepaid Media Rights Cogs PrepaidMediaRightsCogs	-7449000	usd
CY2023	mcom	Prepaid Media Rights Fx Rate Adjustment Value PrepaidMediaRightsFxRateAdjustmentValue	31000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	49000	usd
CY2023Q4	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	928000	usd
CY2022Q4	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	3054000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	10696000	usd
CY2022	mcom	Goodwill Business Combination Value GoodwillBusinessCombinationValue	13826000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	9264000	usd
CY2022	mcom	Goodwill Fx Rate Adjustment Value GoodwillFxRateAdjustmentValue	-1432000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	13826000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	13826000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	13826000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18908000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18298000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16473000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12136000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	2435000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	6162000	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	3075000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2435000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9237000	usd
CY2023	us-gaap	Disposal Group Including Discontinued Operation Depreciation And Amortization DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization	7913000	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Depreciation And Amortization DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization	5416000	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	3010000	usd
CY2022Q4	us-gaap	Other Indefinite Lived Intangible Assets OtherIndefiniteLivedIntangibleAssets	87000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3513000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-246000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3267000	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	3611000	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	2063000	usd
CY2023Q4	mcom	Legal Contingencies Refer To Note Xx LegalContingenciesReferToNoteXx	3978000	usd
CY2022Q4	mcom	Legal Contingencies Refer To Note Xx LegalContingenciesReferToNoteXx	2710000	usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	3144000	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	2693000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1920000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2369000	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	440000	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1113000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	9482000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	8885000	usd
CY2023Q4	us-gaap	Convertible Debt ConvertibleDebt	15370000	usd
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	40418000	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	13528000	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	33244000	usd
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1842000	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	7174000	usd
CY2023	mcom	Convertible Debts ConvertibleDebts	-3144000	usd
CY2022	mcom	Convertible Debts ConvertibleDebts	-4423000	usd
CY2023	mcom	Secured Loan SecuredLoan	-1948000	usd
CY2022	mcom	Secured Loan SecuredLoan	-2055000	usd
CY2023	mcom	Unsecured Loans UnsecuredLoans	-728000	usd
CY2022	mcom	Unsecured Loans UnsecuredLoans	-548000	usd
CY2023	us-gaap	Interest Expense Other InterestExpenseOther	21000	usd
CY2022	us-gaap	Interest Expense Other InterestExpenseOther	115000	usd
CY2023	us-gaap	Interest Expense InterestExpense	-6010000	usd
CY2022	us-gaap	Interest Expense InterestExpense	-7141000	usd
CY2023	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	734000	usd
CY2023	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	928942	shares
CY2023	us-gaap	Debt Instrument Repaid Principal DebtInstrumentRepaidPrincipal	2134000	usd
CY2023	mcom	Gain On Waiver Of Overdue GainOnWaiverOfOverdue	825000	usd
CY2023	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	206000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-61997000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-82050000	usd
CY2023	mcom	Sepas Transaction Costs SepasTransactionCosts	-1611000	usd
CY2023	mcom	Other Sepa Financial Income Expenses Net OtherSepaFinancialIncomeExpensesNet	-2604000	usd
CY2023	mcom	Total Sepa Financial Income Expenses Net TotalSepaFinancialIncomeExpensesNet	-4215000	usd
CY2023Q2	mcom	Warrnts Conversion Description WarrntsConversionDescription	April 27, 2023, two independent board members converted a portion of their deferred salaries, totaling $69, into 1,062 Warrants to purchase shares of Class A Common Stock with a strike price of $174 and 5-years from issuance as expiration date.
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	279	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3600.00
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	279	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	3600.00
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	29172	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.26
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	775	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	157.50
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	28397	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.07
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	58000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	24000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	58000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	24000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	58000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.02	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.03	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.01	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.02	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Deductions Employee Stock Ownership Plan Dividends EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends	-0.01	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Deductions Employee Stock Ownership Plan Dividends EffectiveIncomeTaxRateReconciliationDeductionsEmployeeStockOwnershipPlanDividends	0	pure
CY2023	mcom	Effective Income Tax Rate Reconciliation Goodwill Impairment EffectiveIncomeTaxRateReconciliationGoodwillImpairment	-0.05	pure
CY2022	mcom	Effective Income Tax Rate Reconciliation Goodwill Impairment EffectiveIncomeTaxRateReconciliationGoodwillImpairment	-0.03	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.01	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.17	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.23	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0009	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0003	pure
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	84336000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	76640000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Reserves And Accruals DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals	1148000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Reserves And Accruals DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals	674000	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	1859000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	1026000	usd
CY2023Q4	mcom	Lease Liability LeaseLiability	184000	usd
CY2022Q4	mcom	Lease Liability LeaseLiability	230000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1634000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1633000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	55000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	328000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	89544000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	80203000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	564000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	447000	usd
CY2023Q4	mcom	Right Of Use Assets RightOfUseAssets	-140000	usd
CY2022Q4	mcom	Right Of Use Assets RightOfUseAssets	-198000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	140000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1209000	usd
CY2023Q4	mcom	Deferred Tax Assets Liabilities Gross DeferredTaxAssetsLiabilitiesGross	89404000	usd
CY2022Q4	mcom	Deferred Tax Assets Liabilities Gross DeferredTaxAssetsLiabilitiesGross	78994000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	89404000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	78994000	usd
CY2023Q4	mcom	Valuation Allowance ValuationAllowance	10410000	usd
CY2022Q4	mcom	Valuation Allowance ValuationAllowance	54855000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2023	mcom	Capitalized Amount CapitalizedAmount	2965000	usd
CY2022	mcom	Capitalized Amount CapitalizedAmount	5577000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-62055000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-82074000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1446391	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1446391	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8768	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8768	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-42.90
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-42.90
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-9360.49
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-9360.49
CY2023	mcom	Revenue From Related Party RevenueFromRelatedParty	56000	usd
CY2022	mcom	Combination Of Cash CombinationOfCash	237000	usd
CY2022	mcom	Issuances Of Shares IssuancesOfShares	527425	shares
CY2022	mcom	Repaid In Cash RepaidInCash	254000	usd
CY2022	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	750000	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5683904	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9587	shares
CY2023	us-gaap	Revenues Revenues	9844000	usd
CY2022	us-gaap	Revenues Revenues	15538000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	28975000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	41625000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2439000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2741000	usd
CY2023	us-gaap	Business Development BusinessDevelopment	2837000	usd
CY2022	us-gaap	Business Development BusinessDevelopment	8712000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22917000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25569000	usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	16683000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	10390000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-64007000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-73499000	usd
CY2023	us-gaap	Revenues Revenues	9844000	usd
CY2022	us-gaap	Revenues Revenues	15538000	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	4004000	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	29909000	usd
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001079973-24-000555-index-headers.html	Edgar Link	pending
0001079973-24-000555-index.html	Edgar Link	pending
0001079973-24-000555.txt	Edgar Link	pending
0001079973-24-000555-xbrl.zip	Edgar Link	pending
ex10x21.htm	Edgar Link	pending
ex10x22.htm	Edgar Link	pending
ex10x23.htm	Edgar Link	pending
ex21x1.htm	Edgar Link	pending
ex23x1.htm	Edgar Link	pending
ex31x1.htm	Edgar Link	pending
ex31x2.htm	Edgar Link	pending
ex32x1.htm	Edgar Link	pending
ex32x2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.gif	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_238.jpg	Edgar Link	pending
image_239.jpg	Edgar Link	pending
image_240.jpg	Edgar Link	pending
image_241.jpg	Edgar Link	pending
image_242.jpg	Edgar Link	pending
image_243.jpg	Edgar Link	pending
image_244.jpg	Edgar Link	pending
image_245.jpg	Edgar Link	pending
image_246.jpg	Edgar Link	pending
image_247.jpg	Edgar Link	pending
mcom-20231231.xsd	Edgar Link	pending
mcom_10k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
mcom-20231231_cal.xml	Edgar Link	unprocessable
mcom-20231231_lab.xml	Edgar Link	unprocessable
mcom-20231231_pre.xml	Edgar Link	unprocessable
mcom_10k_htm.xml	Edgar Link	completed
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mcom-20231231_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MCOM
micromobility.com Inc. Stock $mcom

2024 Q2 Form 10-K Financial Statement

#000107997324000555 Filed on April 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MCOM micromobility.com Inc. Stock $mcom

2024 Q2 Form 10-K Financial Statement

#000107997324000555 Filed on April 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MCOM
micromobility.com Inc. Stock $mcom